These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19852016)

  • 21. Comparison of multilabel and single-label classification applied to the prediction of the isoform specificity of cytochrome p450 substrates.
    Michielan L; Terfloth L; Gasteiger J; Moro S
    J Chem Inf Model; 2009 Nov; 49(11):2588-605. PubMed ID: 19883102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymes involved in the metabolism of the carcinogen 2-nitroanisole: evidence for its oxidative detoxication by human cytochromes P450.
    Miksanová M; Sulc M; Rýdlová H; Schmeiser HH; Frei E; Stiborová M
    Chem Res Toxicol; 2004 May; 17(5):663-71. PubMed ID: 15144223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mimicry of phase I drug metabolism--novel methods for metabolite characterization and synthesis.
    Johansson T; Weidolf L; Jurva U
    Rapid Commun Mass Spectrom; 2007; 21(14):2323-31. PubMed ID: 17575570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
    Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
    Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism and structure-reactivity relationships for aromatic hydroxylation by cytochrome P450.
    Bathelt CM; Ridder L; Mulholland AJ; Harvey JN
    Org Biomol Chem; 2004 Oct; 2(20):2998-3005. PubMed ID: 15480465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
    Usmani KA; Hodgson E; Rose RL
    Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the regioselectivity of aromatic hydroxylation and N-oxygenation by cytochrome P450 enzymes.
    Dowers TS; Rock DA; Rock DA; Perkins BN; Jones JP
    Drug Metab Dispos; 2004 Mar; 32(3):328-32. PubMed ID: 14977867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
    Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
    Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid estimation of activation enthalpies for cytochrome-P450-mediated hydroxylations.
    Mayeno AN; Robinson JL; Reisfeld B
    J Comput Chem; 2011 Mar; 32(4):639-57. PubMed ID: 20925096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantum chemical model for prediction of the site of hydroxylation of aromatic substances mediated by cytochrome P450].
    Kharchevnikova NV; Dmitriev AV; Borodina IuV; D'iachkov PN
    Biomed Khim; 2005; 51(3):341-55. PubMed ID: 16104398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of cytochrome P450 xenobiotic metabolism: tethered docking and reactivity derived from ligand molecular orbital analysis.
    Tyzack JD; Williamson MJ; Torella R; Glen RC
    J Chem Inf Model; 2013 Jun; 53(6):1294-305. PubMed ID: 23701380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of density functional theory in drug metabolism studies.
    Rydberg P; Jørgensen FS; Olsen L
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Regioselectivity and Lability of Cytochrome P450 Metabolism Using Quantum Mechanical Simulations.
    Tyzack JD; Hunt PA; Segall MD
    J Chem Inf Model; 2016 Nov; 56(11):2180-2193. PubMed ID: 27753488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction.
    Jones JP; Mysinger M; Korzekwa KR
    Drug Metab Dispos; 2002 Jan; 30(1):7-12. PubMed ID: 11744605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New combined model for the prediction of regioselectivity in cytochrome P450/3A4 mediated metabolism.
    Oh WS; Kim DN; Jung J; Cho KH; No KT
    J Chem Inf Model; 2008 Mar; 48(3):591-601. PubMed ID: 18290640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P450 enzymes: their structure, reactivity, and selectivity-modeled by QM/MM calculations.
    Shaik S; Cohen S; Wang Y; Chen H; Kumar D; Thiel W
    Chem Rev; 2010 Feb; 110(2):949-1017. PubMed ID: 19813749
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of carbon-hydrogen bond dissociation energies on the prediction of the cytochrome P450 mediated major metabolic site of drug-like compounds.
    Drew KL; Reynisson J
    Eur J Med Chem; 2012 Oct; 56():48-55. PubMed ID: 22960693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.